Connect with us

Government

Six Oil Stocks to Buy as the Economy Improves and Energy Prices Rise

Six oil investments to buy as the economy improves and energy prices rise are part of an industry that recently led BoA Global Research to forecast Brent crude soaring to $100 a barrel by 2022. The six oil stocks to buy amid the recovering economy and…

Published

on

Six oil investments to buy as the economy improves and energy prices rise are part of an industry that recently led BoA Global Research to forecast Brent crude soaring to $100 a barrel by 2022.

The six oil stocks to buy amid the recovering economy and increasing oil prices include the country’s biggest refiner of the so-called “black gold” and five stocks given buy ratings from BoA. The forecast of $100 a barrel for Brent crude next year came from BoA’s commodity team, but the company’s equity research staff is not quite as bullish.

Fund-Loving Pension Chairman Predicts Oil Rising to $100 a Barrel Amid Economic Recovery

Aside from short-term pullbacks, oil has been a good investment for more than a year, and that’s likely to continue, said Bob Carlson, who heads the Retirement Watch investment newsletter. Market forces and the major oil producers are likely to drive the price of oil to around $100 and it likely will stay around that level, if global economic growth remains strong, he added.

“I prefer to invest in the commodities themselves instead of companies in commodity businesses,” said Carlson, who also serves as chairman of the Board of Trustees of Virginia’s Fairfax County Employees’ Retirement System with more than $4 billion in assets. “Investing in the commodities avoids potential problems with management, debt levels, regulators, labor and more.”

Funds are the best way for most investors to take positions in commodities, Carlson counseled.

Pension fund and Retirement Watch chief Bob Carlson answers questions from columnist Paul Dykewicz.

Commodity Fund Offers Alternative to Six Oil Stocks to Buy

One good choice is the ETF iShares GSCI Commodity Dynamic Roll (COMT), Carlson continued. The fund seeks to follow the Goldman Sachs Commodity Index, which is more heavily weighted to energy than most other commodity indexes, he added.

Chart courtesy of www.StockCharts.com

COMT invests in most commodities using futures contracts. The fund has gained 9.30% in the last three months and 28.27% for the year to date.

“Another good choice is Parametric Commodity Strategy (EAPCX), an open-end mutual fund,” Carlson said. “This fund also takes most of its commodity positions through futures contracts. The fund’s benchmark is the Bloomberg Commodity Total Return Index, which isn’t as heavily weighted in energy as the GSCI.”

Chart courtesy of www.StockCharts.com

However, EAPCX does not try to track the Bloomberg Commodity Total Return Index, Carlson commented. Instead, EAPCX seeks to beat the index using a rules-based systematic investment process, greater diversification and more active rebalancing, he added.

“The managers don’t forecast the markets or take positions based on forecasts,” Carlson said.

The fund rose 8.94% in the last three months and 21.60% for the year date.

Wall Street Veteran Chooses Largest U.S. Oil Refiner as One of Six Oil Stocks to Buy

“Oil prices topped out in mid-July after OPEC stated it would increase production,” said Bryan Perry, who heads the Cash Machine investment newsletter, as well as the Premium Income, Quick Income Trader, Breakout Profits Trader and Hi-Tech Trader advisory services. As of July 19, WTI crude traded at $66.57/bbl. in what is the sharpest sell-off since late March. Assuming this pullback in crude is an orderly correction, following a torrid move higher year to date, it presents a compelling buying opportunity in some blue-chip energy stocks.”

Paul Dykewicz interviews Bryan Perry at a MoneyShow.

One such stock to consider is Marathon Petroleum Corp. (NYSE:MPC), America’s largest oil refiner, said Perry, who called it his favorite industry pick at the moment. Findlay, Ohio-based Marathon Petroleum Corp. not only has robust operations in refining but in midstream and retail markets, he added.

Chart courtesy of www.StockCharts.com

Refiner’s Resurgence Rates It One of Six Oil Stocks to Buy

Revenues at the company are forecast to jump by 23% to $85 billion in 2021 with earnings of $1.03 per share estimated to soar by 221% to $3.31 in 2022, Perry said. The stock traded at $64.84 in early June and is testing its 200-day moving average around $50, sporting a dividend yield of 4.5%, Perry continued.

If oil prices stabilize, Marathon Petroleum should prove to be a “very savvy purchase” for investors seeking to initiate or add to their energy holdings,” Perry predicted.  

Six Oil Stocks to Buy Gain Economic Support from Stock-Picking Professor

The 13-nation Organization of Petroleum Exporting Countries (OPEC) and its oil-producing allies recently agreed to provide millions of additional barrels of crude oil a day to the global market in the next two years, said Mark Skousen, PhD, who heads the Forecasts & Strategies investment newsletter, as well as the Home Run Trader, Five Star Trader, TNT Trader and the Fast Money Alert trading services. So, it is no surprise that the price of U.S. oil has dropped by 6% to less than $70 on Monday, July 19, added Skousen, a Presidential Fellow in economics at Chapman University.

The drop in oil prices hurt energy producers as the sector was enduring a shakeout due to the recent consolidation in the stock market. But a good contrarian buys on bad news with a view to taking profits when the outlook improves, Skousen counseled.

With the pandemic receding, interest rates near record lows and governments introducing multi-trillion fiscal stimulus around the world, it should not be long before oil prices and companies rebound, Skousen opined.

Mark Skousen, PhD, a descendent of Benjamin Franklin, meets with Paul Dykewicz in Philadelphia.

Money Manager Suggests a Fund and a Natural Gas Company Other than Six Oil Stocks to Buy

“I’m going to get contrarian here: while oil might spike above $100 on a supply shock or geopolitical tension, it’s going to take a lot of inflation and a lot of OPEC supply discipline to keep it there,” said Hilary Kramer, who heads the GameChangers and Value Authority advisory services. “This is not the 1970s, when U.S. energy independence was a cruel dream. If overseas producers talk tough, domestic shale operators will simply drill more wells. So, what do I like in the sector? All the majors are down 10-25%, so all you really need to do is pick up a broad market-cap-weighted basket like the Energy SPDR (NYSE:XLE) and wait for rising crude to lift all the boats.” 

Chart courtesy of www.StockCharts.com

If investors want something more concentrated, here’s an outside-the-box idea: natural gas processor Williams Companies (NYSE:WMB), which at an implied yield of 6.4% is showing significant stress, Kramer counseled. 

Chart courtesy of www.StockCharts.com

“I’d be surprised if cash flow on the horizon will support the dividend, so the market is right in being a little leery of this stock, Kramer said. “But while it will take some creative accounting to maintain a $0.41 quarterly payout, I’m thinking WMB can manage $0.30 per quarter without too much trouble… if management decides they need to cut at all. That’s worth a 4.5% yield, which is pretty good if you’re simply looking for a bond replacement over the next few years.”

Columnist Paul Dykewicz interviews money manager Hilary Kramer, whose premium advisory services include IPO Edge2-Day TraderTurbo Trader and Inner Circle.

And that possibility is a “worst-case scenario,” Kramer said. WMB’s management found a way to keep raising the dividend in every oil slump since 2002 and only cut in 2016 to free up cash for acquisitions, she added.

“At the time, Wall Street cheered,” Kramer recalled. “While I can’t promise that this time around, using this stock for income and not as a trading vehicle is probably the way to go right now.”

BoA Global Research Identifies Five of Six Oil Investments to Buy 

A recent research report by BoA identified five oil stocks as buys. Exxon Mobil Corp. stands out at the top of the group.

Key risks faced by Exxon Mobil include a challenging margin environment, significant delays to the new upstream projects critical to its growth targets and obstacles to capturing the price climate due to cost constraints. However, BoA set a lofty $90 price target for Exxon Mobil, 60.8% above its closing price of $55.96 on July 20.

Chart courtesy of www.StockCharts.com

Occidental Petroleum Corp. (NYSE:OXY) received a $44 price target from BoA that would mark a 73.4% jump from the company’s closing price of $25.37 on July 20. But the company’s downside risks, cited by BoA, include the tough oil and gas environment, potential delays in large-scale projects and exposure to the Middle East and the corresponding political risk it entails.

Chart courtesy of www.StockCharts.com

Hess Earns Spot Among Six Oil Stocks to Buy

Hess Corp. (NYSE:HES) earned a price objective of $115 from BoA, along with a caution to expect the company to show restraint on new spending projects aimed at growing the business. The risks to the forecast include the unpredictable pricing environment, possible slowdowns in drilling that could cause production to slip below expectations and exploratory drilling activities that could hold back the stock’s rise, BoA indicated.

Chart courtesy of www.StockCharts.com

FANG Earns Berth Among Six Oil Stocks to Buy

Diamondback Energy Inc. (NYSE:FANG) garnered a $114 price objective from BoA. However, it faces risks that include the uncertain pricing environment in the oil industry and the possibility of a slower rate of development than currently expected.

Deven Energy Also Is One of the Six Oil Stocks to Buy

Deven Energy Corp. (NYSE:DYN) received a $40 price objective from BoA, 57.9% above the stock’s closing share price of $24.54 on July 20. Challenges include trying to develop production in the Permian Basin and Eagle Ford shale, weak natural gas pricing and a potential global recession, according to BoA.

New Delta Variant of COVID-19 Spread May Affect Six Oil Stocks to Buy

The increasingly transmissible Delta variant of COVID-19 has raised concerns from health experts about increased spread of the virus across the United States. The variant is blamed for new surges in case numbers and deaths. Genetic variants of SARS-CoV-2 have been emerging and circulating around the world throughout the COVID-19 pandemic, according to the Centers for Disease Control and Prevention (CDC). 

For example, the CDC and the U.S. State Department each raised their warnings to the highest levels on July 19 for travel to the United Kingdom. The CDC cautioned to “avoid” traveling there, while the State Department issued a blunt “do not travel” warning for the United Kingdom.

A variant has one or more mutations that differentiate it from other COVID-19 varieties in circulation. The Delta variant is expected to become the dominant coronavirus strain in the United States, according to the CDC. With more than half the U.S. population not fully vaccinated, public health officials caution that a resurgence of COVID-19 cases may well occur this fall when many unvaccinated children return to school.

Progress in increasing the number of people vaccinated from COVID-19 lifts hope that new cases and deaths will keep falling. As of July 19, 186,317,651 people, or 56.1% of the U.S. population, have received at least one dose of a COVID-19 vaccine. The fully vaccinated total 161,473,715 people, or 48.6%, of the U.S. population, according to the CDC.

The Food and Drug Administration recently approved a third COVID-19 vaccine, manufactured by Johnson & Johnson (NYSE:JNJ), which requires only one dose rather than two, as with the first two vaccine providers: Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA).

COVID-19 cases worldwide have reached 191,216,295 and caused 4,101,590 deaths, as of July 20, according to Johns Hopkins University. U.S. COVID-19 cases reached 34,150,195 and caused 609,377 deaths. America has the dreaded distinction as the country with the most COVID-19 cases and deaths.

The six oil investments allow investors to profit amid the pandemic. Rising COVID-19 vaccine availability, improving economic data and a recent $1.9 trillion federal stimulus package should help to lift the prices of the oil investments to buy.

Paul Dykewicz, www.pauldykewicz.com, is an accomplished, award-winning journalist who has written for Dow Jones, the Wall Street JournalInvestor’s Business DailyUSA Today, the Journal of Commerce, Seeking Alpha, GuruFocus and other publications and websites. Paul, who can be followed on Twitter @PaulDykewicz, is the editor of StockInvestor.com and DividendInvestor.com, a writer for both websites and a columnist. He further is editorial director of Eagle Financial Publications in Washington, D.C., where he edits monthly investment newsletters, time-sensitive trading alerts, free e-letters and other investment reports. Paul previously served as business editor of Baltimore’s Daily Record newspaper. Paul also is the author of an inspirational book, “Holy Smokes! Golden Guidance from Notre Dame’s Championship Chaplain,” with a foreword by former national championship-winning football coach Lou Holtz. The book is great as a gift and is endorsed by Joe Montana, Joe Theismann, Ara Parseghian, “Rocket” Ismail, Reggie Brooks, Dick Vitale and many othersCall 202-677-4457 for special pricing!

 

The post Six Oil Stocks to Buy as the Economy Improves and Energy Prices Rise appeared first on Stock Investor.

Read More

Continue Reading

Government

Are Voters Recoiling Against Disorder?

Are Voters Recoiling Against Disorder?

Authored by Michael Barone via The Epoch Times (emphasis ours),

The headlines coming out of the Super…

Published

on

Are Voters Recoiling Against Disorder?

Authored by Michael Barone via The Epoch Times (emphasis ours),

The headlines coming out of the Super Tuesday primaries have got it right. Barring cataclysmic changes, Donald Trump and Joe Biden will be the Republican and Democratic nominees for president in 2024.

(Left) President Joe Biden delivers remarks on canceling student debt at Culver City Julian Dixon Library in Culver City, Calif., on Feb. 21, 2024. (Right) Republican presidential candidate and former U.S. President Donald Trump stands on stage during a campaign event at Big League Dreams Las Vegas in Las Vegas, Nev., on Jan. 27, 2024. (Mario Tama/Getty Images; David Becker/Getty Images)

With Nikki Haley’s withdrawal, there will be no more significantly contested primaries or caucuses—the earliest both parties’ races have been over since something like the current primary-dominated system was put in place in 1972.

The primary results have spotlighted some of both nominees’ weaknesses.

Donald Trump lost high-income, high-educated constituencies, including the entire metro area—aka the Swamp. Many but by no means all Haley votes there were cast by Biden Democrats. Mr. Trump can’t afford to lose too many of the others in target states like Pennsylvania and Michigan.

Majorities and large minorities of voters in overwhelmingly Latino counties in Texas’s Rio Grande Valley and some in Houston voted against Joe Biden, and even more against Senate nominee Rep. Colin Allred (D-Texas).

Returns from Hispanic precincts in New Hampshire and Massachusetts show the same thing. Mr. Biden can’t afford to lose too many Latino votes in target states like Arizona and Georgia.

When Mr. Trump rode down that escalator in 2015, commentators assumed he’d repel Latinos. Instead, Latino voters nationally, and especially the closest eyewitnesses of Biden’s open-border policy, have been trending heavily Republican.

High-income liberal Democrats may sport lawn signs proclaiming, “In this house, we believe ... no human is illegal.” The logical consequence of that belief is an open border. But modest-income folks in border counties know that flows of illegal immigrants result in disorder, disease, and crime.

There is plenty of impatience with increased disorder in election returns below the presidential level. Consider Los Angeles County, America’s largest county, with nearly 10 million people, more people than 40 of the 50 states. It voted 71 percent for Mr. Biden in 2020.

Current returns show county District Attorney George Gascon winning only 21 percent of the vote in the nonpartisan primary. He’ll apparently face Republican Nathan Hochman, a critic of his liberal policies, in November.

Gascon, elected after the May 2020 death of counterfeit-passing suspect George Floyd in Minneapolis, is one of many county prosecutors supported by billionaire George Soros. His policies include not charging juveniles as adults, not seeking higher penalties for gang membership or use of firearms, and bringing fewer misdemeanor cases.

The predictable result has been increased car thefts, burglaries, and personal robberies. Some 120 assistant district attorneys have left the office, and there’s a backlog of 10,000 unprosecuted cases.

More than a dozen other Soros-backed and similarly liberal prosecutors have faced strong opposition or have left office.

St. Louis prosecutor Kim Gardner resigned last May amid lawsuits seeking her removal, Milwaukee’s John Chisholm retired in January, and Baltimore’s Marilyn Mosby was defeated in July 2022 and convicted of perjury in September 2023. Last November, Loudoun County, Virginia, voters (62 percent Biden) ousted liberal Buta Biberaj, who declined to prosecute a transgender student for assault, and in June 2022 voters in San Francisco (85 percent Biden) recalled famed radical Chesa Boudin.

Similarly, this Tuesday, voters in San Francisco passed ballot measures strengthening police powers and requiring treatment of drug-addicted welfare recipients.

In retrospect, it appears the Floyd video, appearing after three months of COVID-19 confinement, sparked a frenzied, even crazed reaction, especially among the highly educated and articulate. One fatal incident was seen as proof that America’s “systemic racism” was worse than ever and that police forces should be defunded and perhaps abolished.

2020 was “the year America went crazy,” I wrote in January 2021, a year in which police funding was actually cut by Democrats in New York, Los Angeles, San Francisco, Seattle, and Denver. A year in which young New York Times (NYT) staffers claimed they were endangered by the publication of Sen. Tom Cotton’s (R-Ark.) opinion article advocating calling in military forces if necessary to stop rioting, as had been done in Detroit in 1967 and Los Angeles in 1992. A craven NYT publisher even fired the editorial page editor for running the article.

Evidence of visible and tangible discontent with increasing violence and its consequences—barren and locked shelves in Manhattan chain drugstores, skyrocketing carjackings in Washington, D.C.—is as unmistakable in polls and election results as it is in daily life in large metropolitan areas. Maybe 2024 will turn out to be the year even liberal America stopped acting crazy.

Chaos and disorder work against incumbents, as they did in 1968 when Democrats saw their party’s popular vote fall from 61 percent to 43 percent.

Views expressed in this article are opinions of the author and do not necessarily reflect the views of The Epoch Times or ZeroHedge.

Tyler Durden Sat, 03/09/2024 - 23:20

Read More

Continue Reading

Government

Veterans Affairs Kept COVID-19 Vaccine Mandate In Place Without Evidence

Veterans Affairs Kept COVID-19 Vaccine Mandate In Place Without Evidence

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

The…

Published

on

Veterans Affairs Kept COVID-19 Vaccine Mandate In Place Without Evidence

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

The U.S. Department of Veterans Affairs (VA) reviewed no data when deciding in 2023 to keep its COVID-19 vaccine mandate in place.

Doses of a COVID-19 vaccine in Washington in a file image. (Jacquelyn Martin/Pool/AFP via Getty Images)

VA Secretary Denis McDonough said on May 1, 2023, that the end of many other federal mandates “will not impact current policies at the Department of Veterans Affairs.”

He said the mandate was remaining for VA health care personnel “to ensure the safety of veterans and our colleagues.”

Mr. McDonough did not cite any studies or other data. A VA spokesperson declined to provide any data that was reviewed when deciding not to rescind the mandate. The Epoch Times submitted a Freedom of Information Act for “all documents outlining which data was relied upon when establishing the mandate when deciding to keep the mandate in place.”

The agency searched for such data and did not find any.

The VA does not even attempt to justify its policies with science, because it can’t,” Leslie Manookian, president and founder of the Health Freedom Defense Fund, told The Epoch Times.

“The VA just trusts that the process and cost of challenging its unfounded policies is so onerous, most people are dissuaded from even trying,” she added.

The VA’s mandate remains in place to this day.

The VA’s website claims that vaccines “help protect you from getting severe illness” and “offer good protection against most COVID-19 variants,” pointing in part to observational data from the U.S. Centers for Disease Control and Prevention (CDC) that estimate the vaccines provide poor protection against symptomatic infection and transient shielding against hospitalization.

There have also been increasing concerns among outside scientists about confirmed side effects like heart inflammation—the VA hid a safety signal it detected for the inflammation—and possible side effects such as tinnitus, which shift the benefit-risk calculus.

President Joe Biden imposed a slate of COVID-19 vaccine mandates in 2021. The VA was the first federal agency to implement a mandate.

President Biden rescinded the mandates in May 2023, citing a drop in COVID-19 cases and hospitalizations. His administration maintains the choice to require vaccines was the right one and saved lives.

“Our administration’s vaccination requirements helped ensure the safety of workers in critical workforces including those in the healthcare and education sectors, protecting themselves and the populations they serve, and strengthening their ability to provide services without disruptions to operations,” the White House said.

Some experts said requiring vaccination meant many younger people were forced to get a vaccine despite the risks potentially outweighing the benefits, leaving fewer doses for older adults.

By mandating the vaccines to younger people and those with natural immunity from having had COVID, older people in the U.S. and other countries did not have access to them, and many people might have died because of that,” Martin Kulldorff, a professor of medicine on leave from Harvard Medical School, told The Epoch Times previously.

The VA was one of just a handful of agencies to keep its mandate in place following the removal of many federal mandates.

“At this time, the vaccine requirement will remain in effect for VA health care personnel, including VA psychologists, pharmacists, social workers, nursing assistants, physical therapists, respiratory therapists, peer specialists, medical support assistants, engineers, housekeepers, and other clinical, administrative, and infrastructure support employees,” Mr. McDonough wrote to VA employees at the time.

This also includes VA volunteers and contractors. Effectively, this means that any Veterans Health Administration (VHA) employee, volunteer, or contractor who works in VHA facilities, visits VHA facilities, or provides direct care to those we serve will still be subject to the vaccine requirement at this time,” he said. “We continue to monitor and discuss this requirement, and we will provide more information about the vaccination requirements for VA health care employees soon. As always, we will process requests for vaccination exceptions in accordance with applicable laws, regulations, and policies.”

The version of the shots cleared in the fall of 2022, and available through the fall of 2023, did not have any clinical trial data supporting them.

A new version was approved in the fall of 2023 because there were indications that the shots not only offered temporary protection but also that the level of protection was lower than what was observed during earlier stages of the pandemic.

Ms. Manookian, whose group has challenged several of the federal mandates, said that the mandate “illustrates the dangers of the administrative state and how these federal agencies have become a law unto themselves.”

Tyler Durden Sat, 03/09/2024 - 22:10

Read More

Continue Reading

Government

Low Iron Levels In Blood Could Trigger Long COVID: Study

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate…

Published

on

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate iron levels in their blood due to a COVID-19 infection could be at greater risk of long COVID.

(Shutterstock)

A new study indicates that problems with iron levels in the bloodstream likely trigger chronic inflammation and other conditions associated with the post-COVID phenomenon. The findings, published on March 1 in Nature Immunology, could offer new ways to treat or prevent the condition.

Long COVID Patients Have Low Iron Levels

Researchers at the University of Cambridge pinpointed low iron as a potential link to long-COVID symptoms thanks to a study they initiated shortly after the start of the pandemic. They recruited people who tested positive for the virus to provide blood samples for analysis over a year, which allowed the researchers to look for post-infection changes in the blood. The researchers looked at 214 samples and found that 45 percent of patients reported symptoms of long COVID that lasted between three and 10 months.

In analyzing the blood samples, the research team noticed that people experiencing long COVID had low iron levels, contributing to anemia and low red blood cell production, just two weeks after they were diagnosed with COVID-19. This was true for patients regardless of age, sex, or the initial severity of their infection.

According to one of the study co-authors, the removal of iron from the bloodstream is a natural process and defense mechanism of the body.

But it can jeopardize a person’s recovery.

When the body has an infection, it responds by removing iron from the bloodstream. This protects us from potentially lethal bacteria that capture the iron in the bloodstream and grow rapidly. It’s an evolutionary response that redistributes iron in the body, and the blood plasma becomes an iron desert,” University of Oxford professor Hal Drakesmith said in a press release. “However, if this goes on for a long time, there is less iron for red blood cells, so oxygen is transported less efficiently affecting metabolism and energy production, and for white blood cells, which need iron to work properly. The protective mechanism ends up becoming a problem.”

The research team believes that consistently low iron levels could explain why individuals with long COVID continue to experience fatigue and difficulty exercising. As such, the researchers suggested iron supplementation to help regulate and prevent the often debilitating symptoms associated with long COVID.

It isn’t necessarily the case that individuals don’t have enough iron in their body, it’s just that it’s trapped in the wrong place,” Aimee Hanson, a postdoctoral researcher at the University of Cambridge who worked on the study, said in the press release. “What we need is a way to remobilize the iron and pull it back into the bloodstream, where it becomes more useful to the red blood cells.”

The research team pointed out that iron supplementation isn’t always straightforward. Achieving the right level of iron varies from person to person. Too much iron can cause stomach issues, ranging from constipation, nausea, and abdominal pain to gastritis and gastric lesions.

1 in 5 Still Affected by Long COVID

COVID-19 has affected nearly 40 percent of Americans, with one in five of those still suffering from symptoms of long COVID, according to the U.S. Centers for Disease Control and Prevention (CDC). Long COVID is marked by health issues that continue at least four weeks after an individual was initially diagnosed with COVID-19. Symptoms can last for days, weeks, months, or years and may include fatigue, cough or chest pain, headache, brain fog, depression or anxiety, digestive issues, and joint or muscle pain.

Tyler Durden Sat, 03/09/2024 - 12:50

Read More

Continue Reading

Trending